title: Production of an osteoinductive demineralised bone matrix powder without the use of organic solvents.
abstract: Demineralised bone matrix (DBM) is produced by grinding cortical bone into a powder, sieving the powder to obtain a desired size range and then demineralising the powder using acid. Protocols for the production of DBM powder have been published since 1965 and the powder can be used in lyophilised form or it can be mixed with a carrier to produce a paste or putty. The powder is generally produced from cortical bone which has been processed to remove blood, bone marrow and bone marrow components, including fat. Removal of fat is accomplished by incorporating incubation in an organic solvent, often chloroform, chloroform/methanol or acetone. The use of organic solvents in a clean room environment in a human tissue bank is problematic and involves operator exposure and the potential for the solvent to be trapped in air filters or recirculated throughout the clean room suite. Consequently, in this study, we have developed a cortical bone washing step which removes fat/lipid without the use of an organic solvent. Bone was prepared from six femoral shafts from three donors by dissecting soft tissue and bisecting the shaft, the shafts were then cut into ~9-10 cm lengths. These struts were then taken through a series of hot water washes at 56-59 °C, centrifugation and decontamination steps. Washed cortical struts were then lyophilised before being ground with a compressed air milling machine. The ground bone was sieved, demineralised, freeze-dried and terminally sterilised with a target dose of 25 kGy gamma irradiation. The DBM powder was evaluated for residual calcium content, in vitro cytotoxicity and osteoinductivity by implantation into the muscle of an athymic mouse. Data indicated that in addition to removing in excess of 97% DNA and extractable soluble protein, the washing protocol reduced lipid 10,000-fold. The processed bone was easily ground without clogging the grinder; the sterilised DBM powder was not cytotoxic but was osteoinductive in the animal model. Therefore, we have developed a method of producing osteoinductive DBM without the need to use organic solvents.
authors.affiliation: NHSBT, Tissue Services R&D, 14 Estuary Banks, Speke, Liverpool, L24 8RB, UK, mark.eagle@nhsbt.nhs.uk.
authors.forename: M J
authors.initials: MJ
authors.lastname: Eagle
authors.forename: P
authors.initials: P
authors.lastname: Rooney
authors.forename: J N
authors.initials: JN
authors.lastname: Kearney
mesh_terms: D000328:Adult; D000368:Aged; D000818:Animals; D018775:Bone Demineralization Technique / Q000379:methods*; D001846:Bone Development / Q000187:drug effects*; D001857:Bone Matrix / Q000737:chemistry*; D018786:Bone Substitutes / Q000008:administration & dosage* / Q000138:chemical synthesis*; D006801:Humans; D008297:Male; D008422:Materials Testing; D051379:Mice; D008819:Mice, Nude; D008875:Middle Aged; D009930:Organic Chemicals / Q000737:chemistry; D010012:Osteogenesis / Q000187:drug effects*; D011208:Powders; D012997:Solvents / Q000737:chemistry
chemical_list: D018786:Bone Substitutes; D009930:Organic Chemicals; D011208:Powders; D012997:Solvents